ProgenCell
- Company typePrivate
- Founded2008
- HeadquartersTijuana, Mexico
- Headcount11–50
- GTM typeB2C
- OfferingServices
ProgenCell firmographics
Firmographics- Name
- ProgenCell
- Legal name
- Progencell
- Website
- https://progencell.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
ProgenCell industry classification
Industry- Product category
- Regenerative Medicine / Stem Cell Therapy Services
- SIC
- Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring) (HLAAABAJ)
- akta.pro secondary industries
- Transplant & Regenerative Medicine Travel Facilitators (THAKAIAJ), Wellness, Preventive & Executive Health Travel Facilitators (THAKAIAK)
Keywords
Where ProgenCell is headquartered
LocationHeadquarters
- HQ city
- Tijuana
- HQ country
- Mexico
- HQ region
- Latin America
Offices1 record
Markets served
ProgenCell business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Stem Cell Treatment Procedures: One-time payment for stem cell therapy procedures. Treatment protocols are individualized based on patient condition and medical evaluation. Pricing varies by condition treated and specific protocol used (knee injections, metabolic protocol, neurological protocol, etc.).
- Financing Services: Third-party financing partners (Klarna, Afterpay, Affirm) provide payment plan options to patients, enabling higher average transaction values and broader patient accessibility.
- IV Therapy and Supportive Treatments: Additional revenue from intravenous therapies, supplements, and supportive treatments that complement stem cell procedures. Includes NAD+, vitamin IVs, and hyperbaric oxygen chamber treatments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Knee Stem Cell Injections - Price range |
| Other | Pay-as-you-go | Financing Available |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
ProgenCell product offering
Product offeringCore offering
ProgenCell is a Tijuana-based stem cell therapy clinic that performs autologous bone marrow-derived mesenchymal stem cell (MSC) treatments across nine specialized protocols covering metabolic, immunological, neurological, ophthalmic, knee/orthopedic, female wellness, male wellness, and male sexual wellness conditions, supported by IV infusions and hyperbaric oxygen therapies. It targets international medical-tourist patients (primarily from the US) and provides bundled concierge services including airport pickup, border crossing assistance, and hotel coordination.
Product overview
ProgenCell is a stem cell therapy clinic offering regenerative medicine treatments primarily using autologous bone marrow-derived stem cells. The core offering consists of nine specialized stem cell treatment protocols organized by medical specialty: Metabolic, Immunological, Neurological, Ophthalmic, Knee, Female Wellness, Male Wellness, Male Sexual Wellness, and IV Therapies. These protocols serve as treatment programs for various chronic degenerative conditions including diabetes, autoimmune disorders, neurological diseases, orthopedic conditions, and anti-aging. The clinic also provides supporting services including telemedicine consultations, free case evaluation, and travel concierge to facilitate international patient access from the U.S. and other countries. Pricing varies by protocol with knee stem cell injections ranging from $1,750 to $3,000, significantly lower than U.S. equivalents of $20,000-$50,000.
Differentiator
Problem solved
Functional benefit
Products and services
- Metabolic Stem Cell Protocol Stem cell treatment protocol targeting metabolic conditions such as diabetes, cardiac insufficiency, hepatic insufficiency, and kidney failure, using autologous bone marrow stem cells to support organ function and regeneration. Intended for patients whose conventional treatment options have been exhausted.
- Immunological Stem Cell Protocol Stem cell treatment protocol designed for immunological conditions including rheumatoid arthritis, fibromyalgia, Sjögren's syndrome, systemic lupus, and psoriatic arthritis. Aims to modulate immune response and reduce chronic inflammation in autoimmune patients.
- Neurological Stem Cell Protocol Specialized protocol for neurological conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Uses bone marrow-derived stem cells administered via intravenous and intrathecal routes to support neural regeneration.
- Ophthalmic Stem Cell Protocol Stem cell treatment protocol for ophthalmological conditions including macular degeneration, diabetic retinopathy, and retinal diseases. Aims to support tissue regeneration in ocular structures.
- Knee Stem Cell Protocol Direct intra-articular stem cell injection protocol for knee conditions including osteoarthritis and cartilage degeneration. Uses autologous bone marrow stem cells (20–25 million per knee) to repair and regenerate cartilage, priced at $1,750–$3,000 per knee versus US alternatives of $20,000–$50,000+.
- Female Wellness Stem Cell Protocol Stem cell protocol designed for female wellness and hormonal balance, targeting conditions related to women's health and anti-aging.
- Male Wellness Stem Cell Protocol Stem cell protocol designed for male wellness and vitality, targeting conditions related to men's health and anti-aging.
- Male Sexual Wellness Stem Cell Protocol Stem cell treatment for erectile dysfunction and male sexual health conditions using regenerative cell therapy.
- IV Therapies Intravenous infusion therapies including vitamin IV, NAD+, and supportive infusions administered alongside stem cell treatments, including hyperbaric oxygen chamber treatment options.
Quantifiable outcome
- 98-99% effectiveness rate in knee stem cell injections - for every 100 patients receiving intra-articular injection, at least 98 receive benefits. Approximately 50-35% receive very good response (pain relief, surgery avoided), 25-35% receive good to regular improvement.
- +3 more outcomes
Companies that use ProgenCell
Customer profileNamed customers4 records
Segments6 records
Ideal customer profiles2 records
ProgenCell technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature4 records
ProgenCell partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Quartz HotelminorPartner hotel located within or near NewCity Medical Plaza complex. Offers accommodation options for international patients traveling for treatment. Described as a modern, 5-star hotel in Tijuana.
Scale indicators2 records
Recent moves4 records
Expansion highlights3 records
ProgenCell competitors and assessment
Company assessmentDirect peers
- MexStemCells: MexStemCells operates a stem cell clinic in Mexico City offering autologous stem cell therapies for orthopedic, neurological, and autoimmune conditions. Headquartered in Mexico with a similar cash-pay, international-patient business model.
- BioXcellerator: BioXcellerator is a stem cell therapy clinic with operations in Colombia and other Latin American locations, offering regenerative treatments for orthopedic, neurological, and autoimmune conditions. Competes in the same international medical-tourism market with similar MSC-based protocols.
- Cellular Hope Institute: Cellular Hope Institute is a Tijuana-based stem cell clinic offering autologous cell therapies for orthopedic, autoimmune, and degenerative conditions, targeting US medical-tourism patients with the same geographic and cost arbitrage as ProgenCell.
- StemGenex: StemGenex is a San Diego-based stem cell therapy provider offering autologous adult stem cell treatments for chronic conditions, positioning itself in the same medical-tourism corridor as ProgenCell. Targets similar patient demographics with similar regenerative protocols.
- Dr. Ernesto Delgado / Delgado & Associates: Independent Tijuana-based regenerative-medicine clinic group offering stem cell therapies to US medical-tourism patients. Competes head-to-head with ProgenCell in the same corridor using similar autologous MSC protocols.
- Regenerative Medicine Institute (RMI): RMI is a Mexico-based regenerative medicine clinic offering stem cell therapy for chronic conditions to international patients. Closely comparable in protocol mix, geography, and medical-tourism orientation.
- Giostar: Giostar operates multiple stem cell therapy clinics in Mexico (including Tijuana) and India, offering autologous and allogeneic MSC-based treatments for chronic degenerative conditions. Directly competes with ProgenCell for medical-tourism patients from the US seeking lower-cost cell therapies.
Broad incumbents
- Mesoblast: Mesoblast is an established clinical-stage biotechnology company developing allogeneic mesenchymal lineage cell therapies for inflammatory and degenerative diseases. Represents the institutional, FDA-pathway counterpoint to ProgenCell's autologous, medically-supervised approach.
- Orthocell / Magellan Stem Cells: Orthocell and Magellan are established regenerative medicine companies delivering autologous cell therapies for orthopedic and musculoskeletal conditions. Comparable on the orthopedic stem cell therapy core, though operating under stricter regulatory frameworks in Australia.
Emerging players
- Celltex Therapeutics: Celltex Therapeutics is a US-based adult mesenchymal stem cell banking and therapy company that has historically served US patients via Mexico-affiliated clinics. Operates in the same autologous MSC therapy space but with a proprietary banking twist.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key highlights7 records
Customer concentration
ProgenCell social profiles
Digital presenceProgenCell compliance and trust
Trust signalCompliance4 records
ProgenCell financial estimates
Financial estimateRevenue estimate
Valuation estimate
ProgenCell leadership team
Management profileNumber of profiles
Profiles3 records
ProgenCell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ProgenCell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ProgenCell
What does ProgenCell do?
ProgenCell is a Tijuana-based stem cell therapy clinic that performs autologous bone marrow-derived mesenchymal stem cell (MSC) treatments across nine specialized protocols covering metabolic, immunological, neurological, ophthalmic, knee/orthopedic, female wellness, male wellness, and male sexual wellness conditions, supported by IV infusions and hyperbaric oxygen therapies. It targets international medical-tourist patients (primarily from the US) and provides bundled concierge services including airport pickup, border crossing assistance, and hotel coordination.
Is ProgenCell a public or private company?
ProgenCell is a private company. It is classified as family owned and is currently operating.
When was ProgenCell founded?
ProgenCell was founded in 2008. It employs 11 to 50 people.
Where is ProgenCell based?
ProgenCell is headquartered in Tijuana, Mexico, in the Latin America region.
How does ProgenCell make money?
Three revenue lines are on record. Stem Cell Treatment Procedures are the primary driver. The others are financing Services and IV Therapy and Supportive Treatments.
Who are ProgenCell's main competitors?
Direct peers on record are MexStemCells, BioXcellerator, Cellular Hope Institute, StemGenex, Dr. Ernesto Delgado / Delgado & Associates, Regenerative Medicine Institute (RMI) and Giostar. Broad incumbents are Mesoblast and Orthocell / Magellan Stem Cells. Celltex Therapeutics is listed as an emerging player.
Does ProgenCell have an API?
No public API is recorded for ProgenCell.
What industry is ProgenCell in?
ProgenCell's product category is Regenerative Medicine / Stem Cell Therapy Services. Its primary akta.pro industry code is HLAAABAJ, Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring), with a secondary code of THAKAIAJ, Transplant & Regenerative Medicine Travel Facilitators. Its SIC code is 8000.